Author:
Wang Jin,Liu Yu,Zhou Xu,Li Zheng,Li Xiang,Xiao Hualiang
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference10 articles.
1. Appelbaum, F. R., Gundacker, H., Head, D. R., et al. (2006). Age and acute myeloid leukemia. Blood, 107, 3481–3485.
2. Andersen, M. K., Larson, R. A., Mauritzson, N., et al. (2002). Balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes, Chromosomes & Cancer, 33, 395–400.
3. Okada, K., Higashiyama, A., Takahata, M., et al. (2012). Complete remission following chemotherapy with low-dose cytosine arabinoside and macrophage colony-stimulating factor/granulocyte colony-stimulating factor in a patient with relapsed acute myeloid leukemia after stem cell transplantation. Internal Medicine, 51, 2937–2941.
4. Lee, J. H., & Choi, S. J. (2005). Anti-leukemic effect of graft versus host disease on bone marrow and extramedullary relapses in acute leukemia. Haematologica, 90, 1380–1388.
5. Juliusson, G., & Swedish AML Group. (2011). Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment. Blood, 117, 3473–3474.